1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. California >
  6. Amneal Pharmaceuticals Acquires Impax Laboratories

M&A Deal Summary

Amneal Pharmaceuticals Acquires Impax Laboratories

On May 7, 2018, Amneal Pharmaceuticals acquired life science company Impax Laboratories

Acquisition Highlights
  • This is Amneal Pharmaceuticals’ 3rd transaction in the Life Science sector.
  • This is Amneal Pharmaceuticals’ 3rd transaction in the United States.
  • This is Amneal Pharmaceuticals’ 1st transaction in California.

M&A Deal Summary
Date 2018-05-07
Target Impax Laboratories
Sector Life Science
Buyer(s) Amneal Pharmaceuticals
Deal Type Merger
Advisor(s) Morgan Stanley (Financial)
Sullivan & Cromwell
McDermott Will & Emery (Legal)

Target

Impax Laboratories

Hayward, California, United States
Entrance to Impax Laboratories' corporate headquarters in Hayward, California.
Entrance to Impax Laboratories' corporate headquarters in Hayward, California.
Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company that applies formulation and development techniques, as well as drug delivery technology, to the development, manufacture and marketing of bioequivalent pharmaceutical products. Impax operates in two segments. These include global pharmaceuticals and Impax pharmaceuticals. The global division develops, manufactures, and distributes generic products. The Impax division develops proprietary brand pharmaceutical products that the Company believes represent improvements to already-approved pharmaceutical products addressing the treatment of central nervous system disorders. Impax Laboratories, Inc. was formed in 1993 and is based in Hayward, California.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Amneal Pharmaceuticals

Bridgewater, New Jersey, United States
Category Company
Founded 2002
Sector Healthcare Services
Employees8,300
Revenue 2.8B USD (2024)
DESCRIPTION

Amneal Pharmaceuticals manufactures and supplies generic pharmaceuticals. The company offers prescription pharmaceutical products in various forms, including oral solids that range from tablets to capsules and soft gels; and liquid-form pharmaceuticals that range from suspensions to solutions. Amneal Pharmaceuticals was founded in 2002 and is based in Bridgewater, New Jersey.

DEAL STATS #
Overall 3 of 6
Sector: Life Science M&A 3 of 5
Type: Merger M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 3 of 6
Year: 2018 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-07 Gemini Laboratories

Bridgewater, New Jersey, United States

Gemini Laboratories LLC is specialty pharmaceutical company provides a prescription products in various therapeutic areas. Gemini Laboratories was founded in 2013 and is based in Bridgewater, New Jersey.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-17 Amneal Deutschland

Gröbenzell, Germany

Amneal Deutschland GmbH is a manufacturer and distributor of pharmaceuticals products. Amneal Deutschland GmbH is based in Gröbenzell, Germany.

Sell -
Mergr

Solution for

Product

Company

Legal